Loading...

Beximco Pharmaceuticals Limited

BXP.LLSE
HealthcareDrug Manufacturers - Specialty & Generic
£38.50
£-1.17(-3.04%)

Beximco Pharmaceuticals Limited (BXP.L) Company Profile & Overview

Explore Beximco Pharmaceuticals Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Beximco Pharmaceuticals Limited (BXP.L) Company Profile & Overview

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEOMr. Iqbal U. Ahmed

Contact Information

880 2 5861 1001
19 Dhanmondi R/A, Dhaka, 1205

Company Facts

6,000 Employees
IPO DateOct 21, 2005
CountryBD
Actively Trading

Frequently Asked Questions